Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Apr 30;25(2):334-335.
doi: 10.5056/jnm19004.

Esophagogastric Junction Outflow Obstruction Caused by Gabapentin

Maximilien Barret  1   2 , Marie-Anne Guillaumot  1   2 , Chloé Léandri  1   2 , Raphael Gaillard  3   4   5 , Stanislas Chaussade  1   2
Affiliations

Esophagogastric Junction Outflow Obstruction Caused by Gabapentin

Maximilien Barret et al. J Neurogastroenterol Motil. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest: None.

Figures

Figure
Figure
High-resolution esophageal manometry and barium esophagogram showing an esophagogastric junction outflow obstruction characterized by a normotonic persistaltic esophageal contraction associated with an elevated median 4-seconds integrated resting pressure (> 15 mmHg) (panel A), and a tight esophagogastric junction with mildly dilated esophagus on esophagogram (panel B). Three months later, after discontinuation of gabapentin, high-resolution manometry (panel C) as well as barium esophagogram (panel D) went back to normal.
See this image and copyright information in PMC

References

    1. Sills GJ. The mechanisms of action of gabapentin and pregabalin. Curr Opin Pharmacol. 2006;6:108–113. doi: 10.1016/j.coph.2005.11.003. - DOI - PubMed
    1. Starmer HM, Yang W, Gourin CG, et al. One-year swallowing outcomes in patients treated with prophylactic gabapentin during radiation-based treatment for oropharyngeal cancer. Dysphagia. 2017;32:437–442. doi: 10.1007/s00455-017-9783-5. - DOI - PubMed
    1. Kirch S, Gegg R, Johns MM, Rubin AD. Globus pharyngeus: effectiveness of treatment with proton pump inhibitors and gabapentin. Ann Otol Rhinol Laryngol. 2013;122:492–495. doi: 10.1177/000348941312200803. - DOI - PubMed
    1. Grossi L, Spezzaferro M, Sacco LF, Marzio L. Effect of baclofen on oesophageal motility and transient lower oesophageal sphincter relaxations in GORD patients: a 48-h manometric study. Neurogastroenterol Motil. 2008;20:760–766. doi: 10.1111/j.1365-2982.2008.01115.x. - DOI - PubMed
    1. Boeckxstaens GE, Beaumont H, Hatlebakk JG, et al. A novel reflux inhibitor lesogaberan (AZD3355) as add-on treatment in patients with GORD with persistent reflux symptoms despite proton pump inhibitor therapy: a randomised placebo-controlled trial. Gut. 2011;60:1182–1188. doi: 10.1136/gut.2010.235630. - DOI - PubMed

LinkOut - more resources